Geron Presents Interim Clinical Data on Its Telomerase Inhibitor ...

Thu, 19 Nov 2009 12:30:00 GMT

MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN - News) today announced the presentation of interim data from its ongoing trial

Geron Corp. spikes on narrower-than-forecast 3Q loss

Fri, 30 Oct 2009 17:30:00 GMT

Filed under: Earnings reports, Technical Analysis

Geron Corporation (GERN) Corporate Event Announcement Notice - Zi...

Sat, 26 Sep 2009 20:44:28 GMT

Geron Corporation (GERN) Expected next earnings release: Announcement date: 10/29/2009 - After Market Earnings Quarter: Q3 Announcement Status: Unconfirmed Expected next investor conference call information: Conference Call Date: 7/31/2009 Conference Call Time (ET): 11:00 AM Conference Call URL:

Geron Corporation to Present at 7th Annual Bio Investor Forum (Bu...

Wed, 29 Oct 2008 11:30:00 GMT

MENLO PARK, Calif.----Geron Corporation today announced that Thomas B. Okarma, Ph.D., M.D., president and chief executive officer, will present an update of the company's product development programs at 9:00 a.m.

Googleâ€™s Chrome browser launches & loves tabs & users (Pimm - P...

Tue, 02 Sep 2008 21:45:08 GMT

Google Chrome Google on Google Chrome - comic book My time with Chrome on the Windows partition of my old MacBook

Geron Corporation awarded UK grant funding for human embryonic st...

Tue, 06 May 2008 10:03:00 GMT

Geron Corporation announced today two grant awards to the University of Edinburgh from the UK Stem Cell Foundation, with funding from the Medical Research Council and Scottish Enterprise. Geron Corporation announced today two grant awards to the University of Edinburgh from the UK Stem Cell

Geron Corporation and Roslin Form Major Cloning Venture-10/05/199...

Mon, 10 May 1999 00:00:00 GMT

Geron Corp., a Menlo Park, Calif.-based biopharmaceutical company, has merged with Roslin Bio-Med, the company formed from the Roslin Institute, the Scottish-based research group involved in transgenic production.

Geron Corporation News - The New York Times

The Geron Corporation announced Wednesday that its plans to begin the first clinical trial using embryonic stem cells had been delayed by federal regulators.

Geron Corporation Profile

PRNewswire | 120 days 3 hours 13 minutes ago NEW YORK, Oct. 10 /PRNewswire/ -- Mergent, Inc., administrator for the HealthShares(TM) Indexes, a series of 5 underlying indexes for the HealthShares(TM) Exchange Traded Funds, today announced the quarterly rebalancing of the Indexes.

Geron Corporation Obtains U.S. Patent For Drug Screening Using Hu...

Menlo Park, CA – January 14, 2003 – Geron Corporation (Nasdaq: GERN) announced today that it has been issued U.S. Patent No. 6,506,574, covering the use of hepatocytes derived from human embryonic stem cells (hESCs) for drug screening. This is the second U.S.

MENLO PARK, Calif., Oct 29, 2008 (BUSINESS WIRE) -- Geron Corpora...

MENLO PARK, Calif., Oct 29, 2008 (BUSINESS WIRE) -- Geron Corporation (NASDAQ GM:GERN) today announced that Thomas B. Okarma, Ph.D., M.D., president and chief executive officer, will present an update of the company's product development programs at 9:00 a.m.

Cancer Vaccines - Geron Corporation Reports Fourth Quarter And An...

The restatement results from our review of recent guidance relating to Emerging Issues Task Force Issue 00-19, "Accounting for Derivative Financial...

Bloomberg.com: Investment Tools

June 12, 2008 17:58 EDT -- Geron Corp. said it may be able to inject its experimental stem cells into people to treat heart failure without triggering a life-threatening response by the body's immune system, in research presented today.

Geron to Present at LCM Healthcare Conference (Business Wire)

Mon, 16 Nov 2009 12:30:00 GMT

MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN - News) today announced that Thomas B. Okarma, Ph.D., M.D., president and chief

Geron Collaborators Publish Data on hESC-Derived Glial Progenitor...

Wed, 11 Nov 2009 12:30:00 GMT

MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN - News) today announced the publication of data showing that oligodendrocyte progenitor cells

Geron Corp. Said Animals Treated With GRNOPC1 Developed Spinal Cy...

Thu, 27 Aug 2009 14:13:49 GMT

8/27/2009 - Geron Corp. (NASDAQ:GERN) said Thursday that some animals treated with its embryonic stem cell product have developed microscopic spinal cysts. The company is testing GRNOPC1 for spinal cord injury and has been testing it on rats and mice in hopes to begin human clinical trials soon.

Geron to Present at Four Investor Conferences (Business Wire)

Mon, 31 Aug 2009 11:30:00 GMT

MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN - News) today announced that the company will present updates of its product

Geron Comments on FDA Hold on Spinal Cord Injury Trial (Business ...

Thu, 27 Aug 2009 11:30:00 GMT

MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN - News) today provided additional comments on the recent clinical hold on its

InvestorSoup.com Issues Investment Report for Geron Corp. (GlobeN...

Tue, 21 Jul 2009 10:50:00 GMT

DALLAS, July 21, 2009 (GLOBE NEWSWIRE) -- InvestorSoup.com announces an investment report featuring biopharmaceutical company Geron Corp. (Nasdaq:GERN - News). The report includes financial, comparative and

Geron to Present at the 8th Annual Needham Life Sciences Conferen...

Wed, 10 Jun 2009 11:30:00 GMT

MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN - News) today announced that Thomas B. Okarma, Ph.D., M.D., president and

Geron Corporation Reports 2009 First Quarter Financial Results an...

Wed, 29 Apr 2009 20:30:00 GMT

MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN - News) today reported financial results for the three months ended March

Geron Appoints Stephen Kelsey as Executive Vice President and Chi...

Mon, 27 Apr 2009 11:30:00 GMT

MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN - News) today announced the appointment of Stephen M. Kelsey, M.D., F.R.C.P.,

Geron Corporation to Present at UBS Global Life Sciences Conferen...

Thu, 18 Sep 2008 11:30:00 GMT

Geron Corporation to Present at UBS Global Life Sciences Conference. - MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN - News) today announced that Thomas B.

Geron Corporation to Present at Thomas Weisel Partners Healthcare...

Thu, 04 Sep 2008 11:30:00 GMT

Geron Corporation to Present at Thomas Weisel Partners Healthcare Conference. - MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN - News) today announced that Thomas B.

Corning Incorporated and Geron Corporation Showcase New Synthetic...

Mon, 21 Sep 2009 12:30:00 GMT

CORNING, N.Y. & MENLO PARK, Calif.--(BUSINESS WIRE)--Corning Incorporated (NYSE: GLW - News) and Geron Corporation (Nasdaq: GERN - News)

Zibb.com: Geron Corporation (Industry News & Blogs)